{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:14:03Z","timestamp":1750824843204},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":9000,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1995]]},"DOI":"10.1254\/jjp.67.117","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T05:13:33Z","timestamp":1201151613000},"page":"117-124","source":"Crossref","is-referenced-by-count":17,"title":["Behavioral Involvement of Central Dopamine and D2 Receptors in l-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Parkinsonian Cynomolgus Monkeys"],"prefix":"10.1016","volume":"67","author":[{"given":"Tetsuo","family":"Akai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motonori","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadako","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.67.117_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-6147(92)90025-2","article-title":"Molecular biology of dopamine receptors","volume":"13","author":"Sibley","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1254\/jjp.67.117_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev.ne.16.030193.001503","article-title":"Recent advances in the molecular biology of dopamine receptors","volume":"16","author":"Gingrich","year":"1993","journal-title":"Annu Rev Neurosci"},{"key":"10.1254\/jjp.67.117_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/syn.890010408","article-title":"Review: D1 dopamine receptor\u2014the search for a function: a critical evaluation of the D,\/D2 dopamine receptor classification and its functional implications","volume":"1","author":"Clark","year":"1987","journal-title":"Synapse"},{"key":"10.1254\/jjp.67.117_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0014-2999(87)90134-8","article-title":"Opposite effects of a D1 and a D2 agonist on oral movements in rats","volume":"134","author":"Johansson","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.67.117_bib5","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1212\/WNL.35.8.1196","article-title":"Combined bromocriptine-levodopa therapy early in Parkinson\u2019s disease","volume":"35","author":"Rinne","year":"1985","journal-title":"Neurology"},{"key":"10.1254\/jjp.67.117_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/WNL.39.3.336","article-title":"Lisuride, a dopamine agonist in the treatment of early Parkinson\u2019s disease","volume":"39","author":"Rinne","year":"1989","journal-title":"Neurology"},{"key":"10.1254\/jjp.67.117_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1476-5381.1985.tb08863.x","article-title":"Failure of SKF 38393-A to relieve parkinsonian symptoms induced by l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset","volume":"85","author":"Close","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1254\/jjp.67.117_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0304-3940(88)90095-X","article-title":"The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 17155 in the MPTP-treated marmoset","volume":"93","author":"Nomoto","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1254\/jjp.67.117_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-2999(88)90322-6","article-title":"The D1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset","volume":"156","author":"Temlett","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.67.117_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/mds.870080205","article-title":"Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors","volume":"8","author":"Gomez-Mancilla","year":"1993","journal-title":"Mov Disord"},{"key":"10.1254\/jjp.67.117_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0014-2999(91)90508-N","article-title":"Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys","volume":"199","author":"Taylor","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.67.117_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(93)90834-5","article-title":"The selective dopamine D, agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys","volume":"235","author":"Vermeulen","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.67.117_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2165\/00003495-198428030-00002","article-title":"Anti-parkinsonian drug today","volume":"28","author":"Quinn","year":"1984","journal-title":"Drugs"},{"key":"10.1254\/jjp.67.117_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0028-3908(89)90036-1","article-title":"Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor","volume":"28","author":"O\u2019Boyle","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1254\/jjp.67.117_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0022-510X(87)90041-4","article-title":"Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonism with l-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP)","volume":"78","author":"Clarke","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.1254\/jjp.67.117_bib16","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.67.117_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(85)90345-0","article-title":"Behavioral stimulation is induced by separate dopamine D1 and D2 receptor sites in reserpine-pretreated but not in normal rats","volume":"113","author":"Arnt","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1254\/jjp.67.117_bib18","series-title":"Handbook of Psychopharmacology","first-page":"231","article-title":"Animal behavioral models of relevance to psychiatry","author":"Kumar","year":"1977"},{"key":"10.1254\/jjp.67.117_bib19","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1073\/pnas.69.8.2145","article-title":"Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the \u201cdopamine receptor\u201d","volume":"69","author":"Kebabian","year":"1972","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1254\/jjp.67.117_bib20","first-page":"432","article-title":"Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities","volume":"42","author":"Lahti","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1254\/jjp.67.117_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1254\/jjp.67.117_bib22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","article-title":"Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine","volume":"350","author":"Van Tol","year":"1991","journal-title":"Nature"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819356094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819356094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T23:20:11Z","timestamp":1605655211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819356094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995]]}},"alternative-id":["S0021519819356094"],"URL":"https:\/\/doi.org\/10.1254\/jjp.67.117","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1995]]}}}